Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma

BACKGROUND: Therapeutic effect and immunosuppressor cell alteration in adding transcatheter arterial chemoembolization (TACE) to sorafenib for advanced stage hepatocellular carcinoma (HCC) remain unclear. AIMS: To examine the therapeutic effect and immunosuppressor cell alteration in adding TACE to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wei‐Chen, Hung, Hao‐Chien, Lee, Jin‐Chiao, Wang, Yu‐Chao, Cheng, Chih‐Hsien, Wu, Tsung‐Han, Lee, Chen‐Fang, Wu, Ting‐Jung, Chou, Hong‐Shiue, Chan, Kun‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941557/
https://www.ncbi.nlm.nih.gov/pubmed/33048465
http://dx.doi.org/10.1002/cnr2.1294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941557/
https://www.ncbi.nlm.nih.gov/pubmed/33048465
http://dx.doi.org/10.1002/cnr2.1294

Ejemplares similares